Results 41 to 50 of about 208,963 (249)
A case of visceral leishmaniasis imported from Armenia
Детские инфекции (Москва), 2023 The relevance of the problem of visceral leishmaniasis is due to the severity of clinical manifestations, as well as the need for immediate etiotropic therapy.
A. L. Rossina +7 more
doaj +1 more source
Canine visceral leishmaniasis: Diagnosis and management of the reservoir living among us
PLoS Neglected Tropical Diseases, 2018 This article reviews essential topics of canine visceral leishmaniasis (CVL) due to Leishmania infantum infection. It focuses on the current serological and molecular diagnostic methods used in epidemiological research and veterinary clinics to diagnose ...
B. Travi +3 more
semanticscholar +1 more source
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives
Clinical Microbiology Reviews, 2018 Research in visceral leishmaniasis in the last decade has been focused on how better to use the existing medicines as monotherapy or in combination. Systematic research by geographical regions has shown that a universal treatment is far from today's ...
F. Alves +16 more
semanticscholar +1 more source
Visceral leishmaniasis in Afghanistan [PDF]
Canadian Medical Association Journal, 2006 Despite being the third most important vector-borne diseases worldwide in terms of burden of disease, the leishmaniases are one of the so-called “neglected diseases.” Since the massive humanitarian re-construction efforts began after the fall of the Taliban in 2002, Afghanistan is ...
Najibullah Mahboob +8 more
openaire +3 more sources
Biomédica: revista del Instituto Nacional de Salud, 2007 Introducción. La leishmaniasis visceral es la forma clínica más grave de la leishmaniasis. Ésta puede ser fatal si no se administra el tratamiento adecuado.
Guillermo Terán-Angel +5 more
doaj +1 more source
Evaluation of a mass distribution programme for fine-mesh impregnated bednets against visceral leishmaniasis in eastern Sudan. [PDF]
, 2007 During an epidemic of visceral leishmaniasis (VL) in eastern Sudan, Médecins Sans Frontières distributed 357,000 insecticide-treated bednets (ITN) to 155 affected villages between May 1999 and March 2001.
Alten +22 more
core +2 more sources
Current and promising novel drug candidates against visceral leishmaniasis
Pure and Applied Chemistry, 2019 Leishmaniasis is a group of zoonotic diseases caused by a trypanosomatid parasite mostly in impoverished populations of low-income countries. In their different forms, leishmaniasis is prevalent in more than 98 countries all over the world and ...
Rosa M. Reguera +7 more
semanticscholar +1 more source
Acute liver failure due to visceral leishmaniasis in Barcelona: a case report
BMC Infectious Diseases, 2019 Background Leishmaniasis is an emerging infectious disease. Due to human migration and tourism, visceral leishmaniasis may become more common in non-endemic areas. In the Mediterranean basin, visceral leishmaniasis typically occurs in rural regions. Case
Iratxe Martinez de Narvajas +10 more
doaj +1 more source
Risk factors for in-hospital mortality of visceral leishmaniasis patients in eastern Uganda. [PDF]
, 2009 OBJECTIVE: To identify risk factors for in-hospital mortality in patients treated for visceral leishmaniasis (VL) in Uganda. METHODS: Retrospective analysis of VL patients' clinical data collected for project monitoring by Médecins Sans Frontières in ...
Bern +20 more
core +3 more sources
Cyclin-dependent kinase 12, a novel drug target for visceral leishmaniasis
Nature, 2018 Visceral leishmaniasis causes considerable mortality and morbidity in many parts of the world. There is an urgent need for the development of new, effective treatments for this disease.
S. Wyllie +31 more
semanticscholar +1 more source